544 employees
uniQure is focused on the research and early development of human gene-based therapies.
1998
$58M
from 4 investors over 4 rounds
uniQure raised $20M on July 1, 2014
Investors: Hercules Capital, Inc.
uniQure raised $58M on July 9, 2013
Investors: Chiesi, Forbion and Coller Capital